AstraZeneca signs $2 bln agreement with Quell to develop cell therapies

AstraZeneca signs $2 bln agreement with Quell to develop cell therapies The agreement includes developing, manufacturing and commercialising cell therapies that have the potential to be curative in type 1 diabetes and inflammatory bowel disease indications. https://ift.tt/jLN6SH4

Comments

Post a Comment

Popular posts from this blog

Cholera outbreaks worsening, spreading to 31 countries: WHO

The UN health agency said the deteriorating outlook was "driven by conflict and poverty", with rural and flood-affected areas especially vulnerable to the disease -- an acute intestinal infection that spreads through food and water contaminated with bacteria, often from faeces. from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/TBNbk8e via gqrds
Read more

SC transfers PIL seeking implementation of law on mental health care to NHRC

The PIL argued that persons with mental illnesses were chained in a faith-based mental asylum in Budaun district of Uttar Pradesh in violation of provisions of the Mental Health Care Act 2017. The court examined the photos of such patients calling it a matter of great concern. from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/hG1drmq via gqrds
Read more